Lower Costs for Everyday Americans Act

H.R. 1397/S. 1164 - Increasing Access to Dental Insurance Act; H.R. 1521: Dental and Optometric Care (DOC) Access Act; S. 5089 Medicare Dental Benefit Act of 2026; S. 891: Bipartisan Health Care Act; S. 2084: Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2025; H.R. 9833/S. 5088: Ensuring Kids Have Access to Medically Necessary Dental Care Act; H.R. 3277/S. 1677: Ensuring Lasting Smiles Act; H.R. 3069/S. 1506: Medicare for All Act; H.R. 2045/S. 939: Medicare Dental, Hearing, and Vision Expansion Act of 2025; H.R. 2041: Hidden Fee Disclosure Act of 2025; H.R. 1768: Lower Costs for Everyday Americans Act; H.R. 1219: Oral Health Products Inclusion Act; H.R. 1160: Health Care Provider Shortage Minimization Act of 2025; H.R. 935: Health Care Workforce Innovation Act of 2025; H.R. 210: Dental Care for Veterans Act; H.R. 9831 Medicaid Dental Benefit Act of 2026; H.R. 4556 Protect Our TEETH Act; H.R. 2001: Action for Dental Health Act; Issues pertaining to the Affordable Care Act (ACA) Enhanced Subsidies (no specific bills); Issues pertaining to Adult Dental Essential Health Benefits (EHB) (no specific bills); Issues pertaining to Medicare (no specific bills); Issues pertaining to Medicaid (no specific bills); Issues pertaining to Letter to Issuers (no specific bills); Issues pertaining to ERISA (no specific bills).

Client expense: $60,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to vaccine access and evidence-based resources for patients and pharmacists (generally, no specific legislation). Tylers Law (H.R. 2004), the ALERT Communities Act (H.R. 1561), and the HERO Act (H.R. 7994), issues related to access to fentanyl test strips and medications for opioid use disorder (MOUD). The Eliminating Thickets to Increase Competition Act (ETHIC) Act (H.R. 3269), the Affordable Prescriptions for Patents Act (H.R. 1768), the Skinny Labels, Big Savings Act (H.R. 6485), the Medication Affordability and Patent Integrity Act (S. 2658), and the Ensuring Timely Access to Generics Act of 2025 (S. 3014), issues related to drug pricing, drug shortages, drug importation plans, and the drug supply chain. Issues related to telehealth and pharmacist provision of testing and vaccination (generally, no specific legislation). Patient access to pharmacist provided services for respiratory illnesses, initiation of oral antivirals, buprenorphine, and other pharmacist services authorized under state law (generally, no specific legislation). Issues related to healthcare workforce shortages (generally, no specific legislation). The Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 929/S. 266), provisions related to supporting health workers mental health and well-being. Issues related to implementation of the Inflation Reduction Act (generally, no specific legislation). The Drug-Price Transparency for Consumers (DTC) Act (H.R.3789), issues related to direct-to-consumer (DTC) prescription drug advertising. The Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646), issues related to funding of FDA. Issues related to the Substance Abuse and Mental Health Services Administration (SAMHSA) decision to end the use of federal funds to purchase fentanyl test strips or other substance test kits, including xylazine and medetomidine test strips, that are distributed for individual use. Issues related to mail-order access to mifepristone (generally, no specific legislation). Issues related to pharmacist deprescribing medications (generally, no specific legislation). The Medication Affordability and Patent Integrity Act, issues related to preventing manufacturers from filing inconsistent information with the Food and Drug Administration and the U.S. Patent and Trademark Office, with the intent to unfairly extend product exclusivity. The Improving Seniors Timely Access to Care Act of 2025 (H.R. 3514) and the Prior Authorization Accountability Act (H.R. 9396), issues related to prior authorization.

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 483: Health Care Efficiency Through Flexibility Act H.R. 5347: Health Care Efficiency Through Flexibility Act H.R. 786/ S. 1460: Preserving Patient Access to Accountable Care Act S.891: Bipartisan Health Care Act H.R. 1768: Lower Costs for Everyday Americans Act S. 1816/ 3514: Improving Seniors Timely Access to Care Act S. 1105: No UPCODE Act S. 2561/ H.R. 5768: Skin Substitute Access and Payment Reform Act H.R. 4773/ S. 3350: ACO Assignment Improvement Act H.R. 4313/ S.2237: Hospital Inpatient Services Modernization Act H.R. 8129: To amend title XVIII of the Social Security Act to establish a full risk ACO program H.R. 6852: Advanced Wound Care and Regenerative Medicine Access and Reform Act Issues related to Medicare payments, Medicare Shared Savings Program, ACO REACH, Medicare Advantage, alternative payment model incentives, telehealth, and fraud, waste, abuse

Client expense: $183,336 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE